iPSirius SAS, [pronounced ip-Sirius], is a French headquartered immuno-oncology firm, seeking to obtain a clinical trial authorization from the U.K.’s Medicines and Healthcare Regulatory Products Agency, to enable it to move its novel therapeutic cancer vaccine into a first-in-human trial in patient... Read more
This company has no teams yet
This company has no offices yet
SERHANT.
13 followers
Ministère de l'Intérieur
5 followers
Highways England
4 followers
The Lede Company
4 followers
NHSRCL
3 followers
AfterQuery
3 followers
east bay regional park district
2 followers
Flourish Research
2 followers
NAV
1 follower
Cville City Schools
1 follower
Data Literacy Academy
1 follower
AIM Intelligent Machines
1 follower